Inari Medical Valuation
| NARIDelisted Stock | USD 79.97 0.00 0.00% |
At this time, the firm appears to be overvalued. Inari Medical retains a regular Real Value of $61.38 per share. The prevalent price of the firm is $79.97. Our model calculates the value of Inari Medical from evaluating the firm fundamentals such as Return On Asset of -0.0321, current valuation of 4.6 B, and Return On Equity of -0.18 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Inari Medical's price fluctuation is very steady at this time. Calculation of the real value of Inari Medical is based on 3 months time horizon. Increasing Inari Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Inari Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Inari Stock. However, Inari Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 79.97 | Real 61.38 | Hype 79.89 | Naive 84.35 |
The intrinsic value of Inari Medical's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Inari Medical's stock price.
Estimating the potential upside or downside of Inari Medical helps investors to forecast how Inari stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Inari Medical more accurately as focusing exclusively on Inari Medical's fundamentals will not take into account other important factors: Inari Medical Total Value Analysis
Inari Medical is now projected to have valuation of 4.6 B with market capitalization of 4.68 B, debt of 32.05 M, and cash on hands of 330.5 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Inari Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.6 B | 4.68 B | 32.05 M | 330.5 M |
Inari Medical Investor Information
About 96.0% of the company shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 275.35. Inari Medical recorded a loss per share of 1.35. The entity had not issued any dividends in recent years. Inari Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Inari Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Inari Medical has an asset utilization ratio of 73.21 percent. This signifies that the Company is making $0.73 for each dollar of assets. An increasing asset utilization means that Inari Medical is more efficient with each dollar of assets it utilizes for everyday operations.Inari Medical Ownership Allocation
Inari Medical has a total of 58.56 Million outstanding shares. The majority of Inari Medical outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Inari Medical to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Inari Medical. Please pay attention to any change in the institutional holdings of Inari Medical as this could imply that something significant has changed or is about to change at the company. Also note that almost two million six hundred twenty-nine thousand five hundred six invesors are currently shorting Inari Medical expressing very little confidence in its future performance.Inari Medical Profitability Analysis
The company reported the previous year's revenue of 493.63 M. Net Loss for the year was (1.64 M) with profit before overhead, payroll, taxes, and interest of 498.76 M.About Inari Medical Valuation
An absolute valuation paradigm, as applied to Inari Stock, attempts to find the value of Inari Medical based on its fundamental and basic technical indicators. By analyzing Inari Medical's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Inari Medical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Inari Medical. We calculate exposure to Inari Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Inari Medical's related companies.Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California. Inari Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 800 people.
Inari Medical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 56.8 M | |
| Quarterly Earnings Growth Y O Y | -0.839 | |
| Forward Price Earnings | 526.3158 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Inari Stock
If you are still planning to invest in Inari Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Inari Medical's history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |